Cheryl Barton
pharmaphorum
AUGUST 7, 2024
Following her senior research positions in academia and seven years with Merck & Co, she joined Dutch investment bank ABN Amro NV as a senior equity analyst to provide coverage on pan-European companies.
pharmaphorum
AUGUST 7, 2024
Following her senior research positions in academia and seven years with Merck & Co, she joined Dutch investment bank ABN Amro NV as a senior equity analyst to provide coverage on pan-European companies.
European Pharmaceutical Review
SEPTEMBER 25, 2023
Gregory’s industrial career spans an employment history with several major pharmaceutical companies. 2002; 74(8): 1760–71. He obtained his BS in Chemistry from St Xavier College, MS in Analytical Chemistry from Governors State University and a PhD in Analytical Chemistry from Northern Illinois University. Cited 2023Feb].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 2, 2020
Despite this political clout, the company also tried to belay its image as a pharma monster, like many others in the industry, by spending generously on charity, donating AIDS drugs both to poor communities in the US, and to developing countries. The era of mega-mergers.
European Pharmaceutical Review
NOVEMBER 15, 2022
Lorrie Vuolo-Schuessler has been involved with ISPE and the GAMP © Community of Practice leadership since 2002 and is currently Chair of the GAMP Americas Steering Committee and a member of the GAMP Global Leadership Team. FDA, Computer Software Assurance for Production and Quality System Software – Draft Guidance. FDA, 2022. .
PharmaShots
MARCH 29, 2023
Shots: Drug patent expiry is when a patent granted to a pharmaceutical company for a particular drug expires, allowing other companies to produce and sell generic versions Like every other utility patent, pharmaceuticals also get market exclusivity of 20 years.
The Checkup by Singlecare
JUNE 7, 2024
Humira is a brand-name medication made by the pharmaceutical company AbbVie, Inc. Cyltezo is an interchangeable biosimilar (similar to a generic, but for biologic drugs like Humira) made by Boehringer Ingelheim Pharmaceuticals, Inc. Humira is a biologic drug and a monoclonal antibody that the FDA approved in 2002.
pharmaphorum
SEPTEMBER 21, 2020
Max Pahlow is vice president & regional commercial strategy leader (EMEA) of immunology & CVM (cardiovascular & metabolism) for the Janssen pharmaceutical companies of Johnson & Johnson.
Let's personalize your content